We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Novita

News List

Novita Pharmaceuticals and China Resources Double Crane Pharmaceutical Enter into an Exclusive License Agreement to Develop and Commercialize Fascin Inhibitor in China firstwordpharma
July 29, 2021
Novita today announced that the Company has entered into an exclusive license agreement (the "Agreement") with China Resources Double Crane Pharmaceutical Co., Ltd. (CRDC), for the development and commercialization of Novita's first-in-class fascin.
Novita Healthcare Ltd to acquire technology platform biospectrumasia
July 17, 2017
The total consideration for the acquisition will comprise $1 million upfront and a deferred cash earn-out of 4x profit before tax in calendar year 2019